Fig. 8
Schematic diagram depicts the antitumor effect of esketamine on esophageal squamous carcinoma cells (ESCC) in vitro and its potential molecular mechanism based on mass spectrometry. Esketamine treatment promotes apoptosis and inhibits proliferation, migration and invasion of ESCC cells, which may be related to its functional suppression of ERRCC6L, AHR and KIF2C